Hudson N, Faulkner G, Smith S J, Langman M J, Hawkey C J, Logan R F
Department of Therapeutics, University Hospital, Nottingham.
Gut. 1995 Aug;37(2):177-81. doi: 10.1136/gut.37.2.177.
Acute peptic ulcer bleeding is associated with a substantial short term mortality but it is generally assumed that in the modern era of effective medical treatment the longer term prognosis is good. This study evaluated 487 patients aged over 60 years who were discharged from Nottingham University and City Hospitals after admission for acute peptic ulcer bleeding during 1986-91 and 480 age and sex matched community controls. Follow up information was obtained from hospital and general practitioner records and from the National Health Service central register. Mortality was compared with control mortality and with rates expected for England and Wales. During a mean follow up of 34 months 142 (29%) of 487 patients died compared with 58 (12%) of 480 community controls and with 81.5 deaths expected (observed/expected (O/E) = 1.74, 95% confidence limits (CL) 1.5 to 2.1). Six years after admission the actuarial survival estimate was only 50% for ulcer patients compared with 76% for community controls and 69% expected. The increased mortality was similar in men and women and was greatest in the 60-74 year age group. Much of the excess mortality was accounted for by deaths from cancer (O/E 34/19.7 = 1.73; CL 1.2 to 2.4), from respiratory disease (O/E 28/10.9 = 2.57; CL 1.7 to 3.7), and in men from vascular disease (O/E 31/22.4 = 1.38; CL 0.9 to 2.0). Eight deaths resulted from recurrent ulcer complications and four deaths from gastric cancers undetected at the index admission. In conclusion, patients discharged after peptic ulcer bleeding had a substantially reduced life expectancy. The increased mortality was predominantly due to a variety of smoking related diseases rather than recurrent peptic ulcer complications. Deaths from recurrent peptic ulcer complications were infrequent and were less than reported in earlier years possibly reflecting prolonged and widespread used of H2 receptor antagonists.
急性消化性溃疡出血与较高的短期死亡率相关,但一般认为在现代有效的药物治疗时代,其长期预后良好。本研究评估了1986年至1991年间因急性消化性溃疡出血入院后从诺丁汉大学医院和城市医院出院的487名60岁以上患者,以及480名年龄和性别匹配的社区对照者。随访信息来自医院和全科医生记录以及国家卫生服务中央登记处。将死亡率与对照死亡率以及英格兰和威尔士的预期死亡率进行比较。在平均34个月的随访期间,487名患者中有142人(29%)死亡,而480名社区对照者中有58人(12%)死亡,预期死亡81.5人(观察值/预期值(O/E)=1.74,95%置信区间(CL)1.5至2.1)。入院六年时,溃疡患者的精算生存率估计仅为50%,而社区对照者为76%,预期为69%。男性和女性的死亡率增加相似,在60 - 74岁年龄组中最高。大部分额外死亡率是由癌症死亡(O/E 34/19.7 = 1.73;CL 1.2至2.4)、呼吸系统疾病死亡(O/E 28/10.9 = 2.57;CL 1.7至3.7)以及男性血管疾病死亡(O/E 31/22.4 = 1.38;CL 0.9至2.0)导致的。8例死亡是由复发性溃疡并发症引起,4例死亡是由初次入院时未发现的胃癌导致。总之,消化性溃疡出血后出院的患者预期寿命大幅降低。死亡率增加主要是由于多种与吸烟相关的疾病,而非复发性消化性溃疡并发症。复发性消化性溃疡并发症导致的死亡很少,且比早年报道的要少,这可能反映了H2受体拮抗剂的长期广泛使用。